These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2029169)

  • 1. Liposomes as antigen vehicles to increase immunogenicity: effects of variation of structural characteristics.
    Tan LS
    Ann Acad Med Singap; 1991 Jan; 20(1):78-83. PubMed ID: 2029169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes as vehicles for vaccines.
    Alving CR; Banerji B; Shiba T; Kotani S; Clements JD; Richards RL
    Prog Clin Biol Res; 1980; 47():339-55. PubMed ID: 7208512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.
    Hamborg M; Rose F; Jorgensen L; Bjorklund K; Pedersen HB; Christensen D; Foged C
    Biochim Biophys Acta; 2014 Aug; 1838(8):2001-10. PubMed ID: 24769435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes as carriers of antigens and adjuvants.
    Alving CR
    J Immunol Methods; 1991 Jun; 140(1):1-13. PubMed ID: 1712030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.
    Watson DS; Endsley AN; Huang L
    Vaccine; 2012 Mar; 30(13):2256-72. PubMed ID: 22306376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
    Zigterman GJ; Snippe H; Jansze M; Willers JM
    J Immunol; 1987 Jan; 138(1):220-5. PubMed ID: 3782798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological adjuvant and vaccine carrier properties of liposomes.
    Gregoriadis G
    J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine approaches for antigen capture by liposomes.
    Zhou S; Luo Y; Lovell JF
    Expert Rev Vaccines; 2023; 22(1):1022-1040. PubMed ID: 37878481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel Phase 1,2-Distearoyl-
    Norling K; Bernasconi V; Agmo Hernández V; Parveen N; Edwards K; Lycke NY; Höök F; Bally M
    ACS Infect Dis; 2019 Nov; 5(11):1867-1878. PubMed ID: 31498993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
    Brgles M; Habjanec L; Halassy B; Tomasić J
    Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome adjuvanticity: influence of dose and protein:lipid ratio on the humoral response to encapsulated and surface-linked antigen.
    Thérien HM; Shahum E; Fortin A
    Cell Immunol; 1991 Sep; 136(2):402-13. PubMed ID: 1873824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens.
    Phillips NC; Gagné L; Ivanoff N; Riveau G
    Vaccine; 1996 Jun; 14(9):898-904. PubMed ID: 8843632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
    Richards RL; Alving CR; Wassef NM
    J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier and adjuvant properties of liposome-borne tumor-specific antigens.
    LeGrue SJ
    Cancer Immunol Immunother; 1984; 17(2):135-41. PubMed ID: 6565518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol inclusion in liposomes affects induction of antigen-specific IgG and IgE antibody production in mice by a surface-linked liposomal antigen.
    Nakano Y; Mori M; Yamamura H; Naito S; Kato H; Taneichi M; Tanaka Y; Komuro K; Uchida T
    Bioconjug Chem; 2002; 13(4):744-9. PubMed ID: 12121129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo.
    Gursel M; Gregoriadis G
    Immunol Lett; 1997 Mar; 55(3):161-5. PubMed ID: 9161882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Rosenkrands I; Lindenstrøm T; Andersen P; Agger EM
    Expert Rev Vaccines; 2007 Oct; 6(5):785-96. PubMed ID: 17931158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens.
    Ullrich SE; Fidler IJ
    J Leukoc Biol; 1992 Nov; 52(5):489-94. PubMed ID: 1431559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal incorporation and immunogenicity of carcinoembryonic antigen.
    Phillips NC; Major PP; Ishida M; Sikorska H
    J Biol Response Mod; 1987 Dec; 6(6):581-6. PubMed ID: 3450782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.